Arcellx (ACLX) Income from Continuing Operations (2021 - 2025)

Arcellx (ACLX) recorded quarterly Income from Continuing Operations of 58112000.0 in Q4 2025, down 4.18% quarter-over-quarter from 55781000.0 in Q3 2025, and down 23.43% on a YoY basis from 75893788.4 in Q4 2024.

Arcellx (ACLX) Income from Continuing Operations (2021 - 2025) Analysis & Trends

Arcellx's Income from Continuing Operations history runs 5 years deep, the most recent figure standing at 58112000.0 for Q4 2025.

  • In Q4 2025, Income from Continuing Operations fell 23.43% year-over-year to 58112000.0; the TTM figure through Dec 2025 stood at 228934000.0 (down 113.39% YoY), while the FY2025 annual figure was 228934000.0, down 113.26% from the prior year.
  • Income from Continuing Operations was 58112000.0 for Q4 2025 at Arcellx, down from 55781000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 19844000.0 in Q4 2023 to a low of 92874000.0 in Q3 2022.
  • Historically, Income from Continuing Operations has averaged 33030250.0 across 5 years, with a median of 27252500.0 in 2023.
  • The sharpest annual moves came in 2023 and 2025: Income from Continuing Operations soared 150.89% in 2023, then tumbled 765.1% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 20698000.0 in 2021, then plunged by 88.39% to 38992000.0 in 2022, then jumped by 150.89% to 19844000.0 in 2023, then tumbled by 337.26% to 47081000.0 in 2024, then fell by 23.43% to 58112000.0 in 2025.
  • The last three Income from Continuing Operations figures came in at 58112000.0 (Q4 2025), 55781000.0 (Q3 2025), and 52771000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Arcellx 6.48 Bn 6.48 Bn - -58.11 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -58.11 Mn
Sep 30, 2025 -55.78 Mn
Jun 30, 2025 -52.77 Mn
Mar 31, 2025 -62.27 Mn
Dec 31, 2024 -47.08 Mn
Sep 30, 2024 -25.84 Mn
Jun 30, 2024 -27.16 Mn
Mar 31, 2024 -7.20 Mn
Dec 31, 2023 19.84 Mn
Sep 30, 2023 -39.34 Mn
Jun 30, 2023 -23.85 Mn
Mar 31, 2023 -27.34 Mn
Dec 31, 2022 -38.99 Mn
Sep 30, 2022 -92.87 Mn
Jun 30, 2022 -30.77 Mn
Mar 31, 2022 -26.04 Mn
Dec 31, 2021 -20.70 Mn
Sep 30, 2021 -17.11 Mn
Jun 30, 2021 -15.93 Mn
Mar 31, 2021 -11.28 Mn